The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
An Integrative Approach to Sarcoidosis and Mixed Connective Tissue Disease - Deanna Windham, DO (2021 Conference) (LDN, low dose naltrexone)
Claire - New Zealand: Fibromyalgia, Connective Tissue Disease, Restless Leg Syndrome (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Claire from New Zealand first got sick when she was around 12 or 13, and was diagnosed with celiac disease.
Low-dose naltrexone: a unique treatment for amyopathic dermatomyositis
Dermatol Online J
15 June 2019
https://escholarship.org/uc/item/89b75552
Dickson Chemist developed a new formulation of LDN which will hopefully improve the outcomes for patients. This new formulation is a more concentrated liquid in the form of drops which are administered under the tongue and absorbed directly from the mucosal lining of the mouth. This sublingual route produces a more rapid absorption bypassing the liver and digestive tract. There are several potential advantages to this, the drug may be more effective and will not be affected by the presence of food stuffs or the hostile environment of the gut.